How BARDA Locked Up COVID-19 Vaccine Manufacturing Capacity For Operation Warp Speed

 
• By Bowman Cox

US agency avoided procurement delays with sole-source awards to two medical countermeasures venture partners worth nearly $900m.

Flexible Biomanufacturing Facility at Texas A&M
ciadm facilities dedicated to 'warp speed' vaccine manufacturing • Source: TAMUS

More from Manufacturing

More from Compliance